You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

phase I clinical study

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Trial (SHR-1826)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Oct 16, 2023

Advanced Malignant Tumor Trial (SHR-5495 for injection)

Not yet recruiting
  • Advanced Malignant Tumor
  • SHR-5495 for injection
  • (no location specified)
Sep 26, 2023

High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

Not yet recruiting
  • High-risk Non-muscle Invasive Bladder Cancer
  • (no location specified)
Oct 25, 2023

Prostate Cancer Trial (HRS-9815 injection)

Not yet recruiting
  • Prostate Cancer
  • HRS-9815 injection
  • (no location specified)
Sep 25, 2023

Non-muscular Invasive Bladder Cancer Trial in Changsha (BCG for therapeutic use)

Not yet recruiting
  • Non-muscular Invasive Bladder Cancer
  • BCG for therapeutic use
  • Changsha, China
    Hunan Cancer Hospital
Oct 20, 2023

Solid Tumor, Positron-Emission Tomography(PET) Trial in Shanghai (68Ga-NOTA-SNA002)

Not yet recruiting
  • Solid Tumor
  • Positron-Emission Tomography(PET)
  • Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Aug 4, 2023

Advanced Malignant Tumor Trial (HRS-2189 Tablets)

Not yet recruiting
  • Advanced Malignant Tumor
  • HRS-2189 Tablets
  • (no location specified)
May 6, 2023

TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Alkaline Glucosodiene Molecules
  • (no location specified)
Jul 14, 2023

Liver Cancer Trial in Kansas City (Stereotactic Body Radiation Treatment)

Not yet recruiting
  • Liver Cancer
  • Stereotactic Body Radiation Treatment
  • Kansas City, Kansas
    University of Kansas Medical Center
Feb 13, 2023

CAR-T Trial in Hangzhou (GC012F injection)

Recruiting
  • CAR-T
  • GC012F injection
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital,College of Medicine, Zhejiang Univ
May 10, 2023

COVID-19 Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo)

Not yet recruiting
  • COVID-19
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Placebo
  • (no location specified)
Sep 22, 2023

NSCLC, Solid Tumor Trial in Tianjin (HS-20117)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Solid Tumor
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jul 10, 2023

COVID-19 Trial (Recombinant variant COVID-19 vaccine(Sf9 cell))

Not yet recruiting
  • COVID-19
  • Recombinant variant COVID-19 vaccine(Sf9 cell)
  • (no location specified)
Mar 10, 2023

Recurrent DLBCL, Refractory Diffuse Large B-cell Lymphoma Trial in Tianjin (RC19D2 cell injection)

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-cell Lymphoma
  • RC19D2 cell injection
  • Tianjin, Tianjin, China
    Hematology Hospital of the Chinese Academy of Medical Sciences
Sep 14, 2023

Advanced Solid Tumor Trial (HLX43)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Oct 30, 2023

Healthy Trial (SHR-2001, Placebo)

Not yet recruiting
  • Healthy
  • (no location specified)
Jul 4, 2023

AML, MDS Trial in Tianjin (XZB-0004)

Not yet recruiting
  • AML
  • MDS
  • Tianjin, Tianjin, China
    Hematology Hospital, Chinese Academy of Medical Sciences
Feb 13, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • Saline
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

Advanced Solid Tumors Trial in China (SPH4336 Tablets)

Active, not recruiting
  • Advanced Solid Tumors
  • SPH4336 Tablets
  • Jinan, Shandong, China
  • +3 more
Jun 6, 2023

Advanced Malignancies Trial in Guangzhou (BRY812 for injection)

Not yet recruiting
  • Advanced Malignancies
  • BRY812 for injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital，Sun Yat-sen University
Sep 7, 2023

Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma Trial in Beijing (JS203 for Injection)

Not yet recruiting
  • Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
  • JS203 for Injection
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 11, 2022

Healthy Trial in Shanghai (SR750 tablet, Placebo)

Recruiting
  • Healthy
  • SR750 tablet
  • Placebo
  • Shanghai, China
    Shanghai Clinical Research Center Phase I Clinical Research Unit
Mar 1, 2023

Rheumatoid Arthritis Trial (VC005 tablets, VC005 Tablets Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • VC005 tablets
  • VC005 Tablets Placebo
  • (no location specified)
May 24, 2023

Leukemia, Myeloid, Acute Trial in Guangzhou, Hangzhou (BG1805)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • BG1805
  • Guangzhou, Guangdong, China
  • +2 more
Nov 1, 2023

Advanced Malignant Cancer Trial (SHR-2022 Injection)

Not yet recruiting
  • Advanced Malignant Cancer
  • SHR-2022 Injection
  • (no location specified)
Nov 8, 2023